Inozyme Pharma, Inc. announced the appointment of Sanjay S. Subramanian, M.S., MBA, as chief financial officer, effective as of the later of March 21, 2022 and the date immediately following the date of the filing of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, and Soojin Kim, Ph.D., as senior vice president and chief technical operations officer.
March 8, 2022
· 7 min read